Articles
Clinical Neuropsychopharmacology and Addiction
Brexpiprazole in the Management of Schizophrenia and Comorbid Substance Use Disorders: A Narrative Review of Efficacy, Safety, and Real-World Evidence (2020–2026)
Miriam Olivola, Nicolaja Girone, Andrea Crippa, Monica Macellaro, Vassilis Martiadis, Fabiola Raffone, Tiziano Prodi, Natascia Brondino, Roberta Anniverno, Bernardo Dell’Osso
2026, 2(1): 3. doi: 10.53941/cna.2026.100003
Retrospective Observations from a Pilot Study on the Feasibility and Safety of Medication Reduction or Withdrawal in Children with Autism Spectrum Disorder Taking Cannabidiol-Rich Oil
Alysson Madruga de Liz, Antonio Inserra, Antonella Campanale, Linério Ribeiro de Novais, Jr., Raquel Alberti, Diogo Alexandre Gomes, Kelser de Souza Kock, Rafael Mariano de Bitencourt, Paulo César Trevisol Bittencourt
2025, 1(1): 7. doi: 10.53941/cna.2025.100007
Suite 4002 Level 4, 447 Collins Street, Melbourne, Victoria 3000, Australia
General Inquiries: info@sciltp.com